InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the complete record of transactions filed by O'Gorman Cedric. Insider active across 1 company, notably Relmada Therapeutics, INC.. Aggregated, 1 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €30k. History available since 23 May 2023. The latest transaction was disclosed on 23 May 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条